Enteric reabsorption processes and their impact on drug pharmacokinetics

[1]  R. Pullakhandam,et al.  Iron and Zinc Homeostasis and Interactions: Does Enteric Zinc Excretion Cross-Talk with Intestinal Iron Absorption? , 2019, Nutrients.

[2]  R. Brundage,et al.  A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies , 2018, European journal of drug metabolism and pharmacokinetics.

[3]  R. Brundage,et al.  Modeling Enterohepatic Circulation , 2017, Current Pharmacology Reports.

[4]  S. Jaiswal,et al.  Role of enterohepatic recirculation in drug disposition: cooperation and complications , 2016, Drug metabolism reviews.

[5]  M. Lavielle.  Simulation of Longitudinal Data , 2015 .

[6]  C. Landersdorfer,et al.  Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans , 2015, AAPS Journal.

[7]  M. Ibarra,et al.  Population pharmacokinetic model to analyze nevirapine multiple-peaks profile after a single oral dose , 2014, Journal of Pharmacokinetics and Pharmacodynamics.

[8]  Jingwei Shao,et al.  Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics. , 2014, Drug discovery today.

[9]  H. Derendorf,et al.  Sex related differences on valproic acid pharmacokinetics after oral single dose , 2013, Journal of Pharmacokinetics and Pharmacodynamics.

[10]  G. M. Pollack,et al.  Influence of Enterohepatic Recycling on the Time Course of Brain-to-Blood Partitioning of Valproic Acid in Rats , 2012, Drug Metabolism and Disposition.

[11]  Jeannie M. Padowski,et al.  The influence of distributional kinetics into a peripheral compartment on the pharmacokinetics of substrate partitioning between blood and brain tissue , 2011, Journal of Pharmacokinetics and Pharmacodynamics.

[12]  A. Scaramelli,et al.  Influence of Efflux Transporters on Drug Metabolism , 2011, Clinical pharmacokinetics.

[13]  Dion R. Brocks,et al.  Multiple Peaking Phenomena in Pharmacokinetic Disposition , 2010, Clinical pharmacokinetics.

[14]  Yuichi Sugiyama,et al.  In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. , 2009, Drug metabolism and pharmacokinetics.

[15]  A. Hofmann.  The enterohepatic circulation of bile acids in mammals: form and functions. , 2009, Frontiers in bioscience.

[16]  Hitomi Mori,et al.  Interaction Between Valproic Acid and Carbapenem Antibiotics , 2007, Drug metabolism reviews.

[17]  Gary M. Pollack,et al.  Physiologic and metabolic influences on enterohepatic recirculation: Simulations based upon the disposition of valproic acid in the rat , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[18]  K. Yamaoka,et al.  Analysis of enterohepatic circulation of cefixime in rat by fast inverse Laplace transform (FILT) , 1990, Journal of Pharmacokinetics and Biopharmaceutics.

[19]  L. Aarons,et al.  Estimation of area under the curve for drugs subject to enterohepatic cycling , 1985, Journal of Pharmacokinetics and Biopharmaceutics.

[20]  L. Granero,et al.  General Treatment of the Enterohepatic Recirculation of Drugs and Its Influence on the Area Under the Plasma Level Curves, Bioavailability, and Clearance , 1992, Pharmaceutical Research.

[21]  Yuichi Sugiyama,et al.  Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[22]  S. Horkovics-Kovats.  Efficiency of Enterohepatic Circulation, its Determination and Influence on Drug Bioavailability , 1999, Arzneimittelforschung.

[23]  T. Macgregor,et al.  Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers , 1999, Biopharmaceutics & drug disposition.

[24]  T. Hasegawa,et al.  Possible Mechanism by Which the Carbapenem Antibiotic Panipenem Decreases the Concentration of Valproic Acid in Plasma in Rats , 1998, Antimicrobial Agents and Chemotherapy.

[25]  E. Zajac,et al.  Postabsorption Concentration Peaks with Brand‐Name and Generic Verapamil: A Double‐Blind, Crossover Study in Elderly Hypertensive Patients , 1997, Journal of clinical pharmacology.

[26]  K. Brouwer,et al.  Hepatobiliary disposition of valproic acid and valproate glucuronide: Use of a pharmacokinetic model to examine the rate‐limiting steps and potential sites of drug interactions , 1996, Hepatology.

[27]  M. Dobrinska.  Enterohepatic Circulation of Drugs , 1989, Journal of clinical pharmacology.

[28]  L. Aarons,et al.  Interpretation of area under the curve measurements for drugs subject to enterohepatic cycling. , 1985, Journal of Pharmacy and Science.

[29]  R. Miller,et al.  Pharmacokinetics and bioavailability of cimetidine in humans. , 1980, Journal of pharmaceutical sciences.

[30]  T. Walle,et al.  Propranolol glucuronide cumulation during long‐term propranolol therapy: A proposed storage mechanism for propranolol , 1979, Clinical pharmacology and therapeutics.

[31]  W. P. Gordon,et al.  The secretion of methadone and its major metabolite in the gastric juice of humans: comparison with blood and salivary concentrations. , 1976, Drug metabolism and disposition: the biological fate of chemicals.

[32]  H. Dencker,et al.  Intestinal absorption, demethylation, and enterohepatic circulation of imipramine , 1976, Clinical pharmacology and therapeutics.

[33]  K Siersbaek-Nielsen,et al.  Phenytoin tolerance tests. , 1971, British medical journal.

[34]  B. Brodie,et al.  The gastric secretion of drugs: a pH partition hypothesis. , 1957, The Journal of pharmacology and experimental therapeutics.